TGF-β-induced EMT can upregulate chemokine receptors, including CXCR4, CXCR5, CCR7 and CCR8 in cancer cells, thus enabling them to follow chemotactic gradients to lymphatic vessels as described above [72]. This evidence concerns the gene TGFB1 and cancer.